Jim Cramer says to parse the Dow for recession-resilient stocks

Jim Cramer says to parse the Dow for recession-resilient stocks


Jim Cramer on The Fed's hawkish inflation comments on Wednesday

CNBC’s Jim Cramer on Thursday advised investors on where to look for stocks that can withstand a potential economic downturn.

“The Dow Jones Industrial Average is filled with relatively cheap stocks because traders assume these 30 old-line companies are the most vulnerable to a recession. But that’s not true: That’s wrong. The Dow components all know how to handle a recession,” he said.

Dow stocks that Cramer has touted as recession-resilient names in recent weeks include Johnson & Johnson and Procter & Gamble

The Federal Reserve indicated that it doesn’t plan to stop raising interest rates anytime soon after its meeting on Wednesday, which has rocked the markets and increased Wall Street’s fears of a potential recession.

Stocks fell on Thursday for a fourth consecutive trading session, with the Dow falling the least of the major indexes, by percentage. The blue chip index slipped 0.46% while the S&P 500 and Nasdaq Composite lost 1.06% and 1.73%, respectively.

Cramer also reiterated his advice to sell volatile tech stocks in favor of financial, oil and health care names. Those stocks “can go up without causing inflation because they’re more conservative,” he said.

Disclaimer: Cramer’s Charitable Trust owns shares of Johnson & Johnson and Procter & Gamble.

Jim Cramer says to parse the Dow for recession-resilient stocks

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More